United States · FDA National Drug Code directory
IBUPROFEN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0363-1610_13af6333-7380-e54c-e063-6294a90aaa35
- Product NDC
- 0363-1610
- Form
- CAPSULE, LIQUID FILLED
- Composition / generic term
- IBUPROFEN
- Labeler
- WALGREENS
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160127
- Source listing expiry
- 20261231
Source-listed ingredients
- IBUPROFEN — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0363-1610-23) · 0363-1610-23
- 300 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0363-1610-31) · 0363-1610-31
- 40 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0363-1610-44) · 0363-1610-44
- 160 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0363-1610-66) · 0363-1610-66
- 80 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0363-1610-80) · 0363-1610-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →